Literature DB >> 27155388

Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells.

Alba Bosquet1, Sandra Guaita-Esteruelas1, Paula Saavedra1, Ricardo Rodríguez-Calvo1, Mercedes Heras1, Josefa Girona1, Lluís Masana2.   

Abstract

BACKGROUND AND AIMS: Fatty acid binding protein 4 (FABP4) is an intracellular fatty acid (FA) carrier protein that is, in part, secreted into circulation. Circulating FABP4 levels are increased in obesity, diabetes and other insulin resistance (IR) diseases. FAs contribute to IR by promoting endoplasmic reticulum stress (ER stress) and altering the insulin signaling pathway. The effect of FABP4 on ER stress in the liver is not known. The aim of this study was to investigate whether exogenous FABP4 (eFABP4) is involved in the lipid-induced ER stress in the liver.
METHODS: HepG2 cells were cultured with eFABP4 (40 ng/ml) with or without linoleic acid (LA, 200 μM) for 18 h. The expression of ER stress-related markers was determined by Western blotting (ATF6, EIF2α, IRE1 and ubiquitin) and real-time PCR (ATF6, CHOP, EIF2α and IRE1). Apoptosis was studied by flow cytometry using Annexin V-FITC and propidium iodide staining.
RESULTS: eFABP4 increased the ER stress markers ATF6 and IRE1 in HepG2 cells. This effect led to insulin resistance mediated by changes in AKT and JNK phosphorylation. Furthermore, eFABP4 significantly induced both apoptosis, as assessed by flow cytometry, and CHOP expression, without affecting necrosis and ubiquitination. The presence of LA increased the ER stress response induced by eFABP4.
CONCLUSIONS: eFABP4, per se, induces ER stress and potentiates the effect of LA in HepG2 cells, suggesting that FABP4 could be a link between obesity-associated metabolic abnormalities and hepatic IR mechanisms.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Fatty acid; Fatty acid/binding protein; Fatty acid/transport; Hepatocytes; Linoleate; Signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27155388     DOI: 10.1016/j.atherosclerosis.2016.04.012

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

1.  Cellular growth and tube formation of HTR8/SVneo trophoblast: effects of exogenously added fatty acid-binding protein-4 and its inhibitor.

Authors:  Sanjay Basak; Arnab Sarkar; Santosh Mathapati; Asim K Duttaroy
Journal:  Mol Cell Biochem       Date:  2017-06-15       Impact factor: 3.396

2.  Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.

Authors:  Zi Long; Meng Cao; Shuhao Su; Guangyuan Wu; Fansen Meng; Hao Wu; Jiangzheng Liu; Weihua Yu; Kamran Atabai; Xin Wang
Journal:  Free Radic Biol Med       Date:  2017-09-21       Impact factor: 7.376

3.  Decreased expression levels of ELOVL6 indicate poor prognosis in hepatocellular carcinoma.

Authors:  Hui Li; Xianling Wang; Jun Tang; Haibo Zhao; Min Duan
Journal:  Oncol Lett       Date:  2019-10-09       Impact factor: 2.967

4.  Exogenous FABP4 interferes with differentiation, promotes lipolysis and inflammation in adipocytes.

Authors:  Hui-Xia Dou; Ting Wang; Hai-Xia Su; Ding-Ding Gao; Ye-Chun Xu; Ying-Xia Li; He-Yao Wang
Journal:  Endocrine       Date:  2019-12-16       Impact factor: 3.633

5.  Insulin and diet-induced changes in the ubiquitin-modified proteome of rat liver.

Authors:  Shilpa R Nagarajan; Amanda E Brandon; Jessie A McKenna; Harrison C Shtein; Thinh Q Nguyen; Eurwin Suryana; Philip Poronnik; Gregory J Cooney; Darren N Saunders; Andrew J Hoy
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

Review 6.  Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.

Authors:  Masato Furuhashi
Journal:  J Atheroscler Thromb       Date:  2019-02-07       Impact factor: 4.928

Review 7.  Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma.

Authors:  Moritz Peiseler; Frank Tacke
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

8.  Gegen Qinlian Decoction Ameliorates Hepatic Insulin Resistance by Silent Information Regulator1 (SIRT1)-Dependent Deacetylation of Forkhead Box O1 (FOXO1).

Authors:  Miao Sui; Guofang Chen; Xiaodong Mao; Xiao Wei; Yu Chen; Chao Liu; Yaofu Fan
Journal:  Med Sci Monit       Date:  2019-11-13

9.  Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms.

Authors:  Ricardo Rodríguez-Calvo; Sara Samino; Josefa Girona; Neus Martínez-Micaelo; Pere Ràfols; María García-Altares; Sandra Guaita-Esteruelas; Alexandra Junza; Mercedes Heras; Oscar Yanes; Xavier Correig; Lluis Masana
Journal:  Biomolecules       Date:  2020-09-03

10.  FABP4 inhibitor BMS309403 protects against hypoxia-induced H9c2 cardiomyocyte apoptosis through attenuating endoplasmic reticulum stress.

Authors:  Fuqiang Sun; Jiangchuan Du; Hongbin Li; Shuang Hao; Guochang Zhao; Fanfan Lu
Journal:  J Cell Mol Med       Date:  2020-09-07       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.